ArticleMolecular cancer2018

Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer.

Yuan-Chin Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.